Private company

R-Pharm

Logo: Tirdanir, Public domain, via Wikimedia Commons3

Largest pharmaceutical company of Russia

R-Pharm (Russian: Р-Фарм) is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection.2 It was founded by Aleksey Repik.1 It employed 3,600 people.1 Its revenue was ₽56.7 billion in 2017.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 20, 2026.

Overview

2001Founded1
  • Industrypharmaceutical industry1
  • HeadquartersMoscow1
  • Websiter-pharm.com/en
  • Legal formclosed joint-stock company, joint-stock company1

See how the biggest companies compare on our leaderboards

R-Pharm (Russian: Р-Фарм) is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection.2

Corporate structure

R-Pharm sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

The story

Founded by Aleksey Repik in 2001.1

Leadership

Who has led R-Pharm, and when. Pick a name to see everywhere that person has worked.

Subsidiaries and ownership

Subsidiaries

From Wikidata.1

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

  • 201756.7B RUB1

Timeline

  1. 2001Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3